Sorafenib administered using a high-dose, pulsatile regimen...

Cancer Chemotherapy and Pharmacology 2020 / 5 Vol. 85; Iss. 5

Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study

Mammatas, L. H., Zandvliet, A. S., Rovithi, M., Honeywell, R. J., Swart, E. L., Peters, G. J., Menke-van der Houven van Oordt, C. W., Verheul, H. M. W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
85
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-020-04065-5
Date:
May, 2020
File:
PDF, 946 KB
2020
Conversion to is in progress
Conversion to is failed